The Definition and Risks of Cytokine Release Syndrome-Like in 11 COVID-19-Infected Pneumonia Critically Ill Patients: Disease Characteristics and Retrospective Analysis

doi 10.1101/2020.02.26.20026989
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

Care for Critically Ill Patients With COVID-19

JAMA - Journal of the American Medical Association
Medicine
2020English

Case Study: A Patient With Asthma, Covid-19 Pneumonia and Cytokine Release Syndrome Treated With Corticosteroids and Tocilizumab

Wits Journal of Clinical Medicine
2020English

Adjuvant Corticosteroid Therapy for Critically Ill Patients With COVID-19

2020English

Severe Atypical Pneumonia in Critically Ill Patients: A Retrospective Multicenter Study

Annals of Intensive Care
Critical CareIntensive Care Medicine
2018English

Prognosis When Using Extracorporeal Membrane Oxygenation (ECMO) for Critically Ill COVID-19 Patients in China: A Retrospective Case Series

Critical Care
Critical CareIntensive Care Medicine
2020English

Correlation Analysis Between Disease Severity and Inflammation-Related Parameters in Patients With COVID-19 Pneumonia

2020English

Permissive Underfeeding, Cytokine Profiles and Outcomes in Critically Ill Patients

PLoS ONE
Multidisciplinary
2019English

The Clinical Characteristics and Mortal Causes Analysis of COVID-19 Death Patients

2020English

Clinical Characteristics and Durations of Hospitalized Patients With COVID-19 in Beijing: A Retrospective Cohort Study

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy